摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-(6-iodo-1-hexynyl)-3-(1-methyl-2(S)-pyrrolidinylmethoxy)pyridine | 820231-98-9

中文名称
——
中文别名
——
英文名称
5-(6-iodo-1-hexynyl)-3-(1-methyl-2(S)-pyrrolidinylmethoxy)pyridine
英文别名
3-(6-iodohex-1-ynyl)-5-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]pyridine
5-(6-iodo-1-hexynyl)-3-(1-methyl-2(S)-pyrrolidinylmethoxy)pyridine化学式
CAS
820231-98-9
化学式
C17H23IN2O
mdl
——
分子量
398.287
InChiKey
JUYVLWANRQTJCC-INIZCTEOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    469.1±40.0 °C(Predicted)
  • 密度:
    1.43±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.4
  • 重原子数:
    21
  • 可旋转键数:
    7
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.59
  • 拓扑面积:
    25.4
  • 氢给体数:
    0
  • 氢受体数:
    3

SDS

SDS:c507b70602f16b079300818d17b9b9b3
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5-(6-iodo-1-hexynyl)-3-(1-methyl-2(S)-pyrrolidinylmethoxy)pyridine 在 silver fluoride 作用下, 以 乙腈 为溶剂, 反应 10.0h, 以57%的产率得到ZW-110
    参考文献:
    名称:
    Novel Pyridyl Ring C5 Substituted Analogues of Epibatidine and 3-(1-Methyl-2(S)- pyrrolidinylmethoxy)pyridine (A-84543) as Highly Selective Agents for Neuronal Nicotinic Acetylcholine Receptors Containing β2 Subunits
    摘要:
    Introduction of a hydrophobic or hydrogen-bonding alkynyl group into the C5 position of the pyridyl ring of epibatidine and A-84543 significantly increased the selectivity for neuronal nicotinic acetylcholine receptors (nAChRs) containing beta 2 subunits over nACbRs containing beta 4 subunits (K-i ratio up to 92000-fold). Our data indicate that the extracellular domains of the nAChRs are sufficiently different to allow for the design of novel ligands with high affinity and selectivity for the nAChR subtypes.
    DOI:
    10.1021/jm0492406
  • 作为产物:
    描述:
    N-甲基-L-脯氨醇 在 palladium on activated charcoal 咪唑copper(l) iodide 、 sodium hydride 、 potassium carbonate三苯基膦 作用下, 以 乙二醇二甲醚二氯甲烷N,N-二甲基甲酰胺 为溶剂, 反应 125.0h, 生成 5-(6-iodo-1-hexynyl)-3-(1-methyl-2(S)-pyrrolidinylmethoxy)pyridine
    参考文献:
    名称:
    Novel Pyridyl Ring C5 Substituted Analogues of Epibatidine and 3-(1-Methyl-2(S)- pyrrolidinylmethoxy)pyridine (A-84543) as Highly Selective Agents for Neuronal Nicotinic Acetylcholine Receptors Containing β2 Subunits
    摘要:
    Introduction of a hydrophobic or hydrogen-bonding alkynyl group into the C5 position of the pyridyl ring of epibatidine and A-84543 significantly increased the selectivity for neuronal nicotinic acetylcholine receptors (nAChRs) containing beta 2 subunits over nACbRs containing beta 4 subunits (K-i ratio up to 92000-fold). Our data indicate that the extracellular domains of the nAChRs are sufficiently different to allow for the design of novel ligands with high affinity and selectivity for the nAChR subtypes.
    DOI:
    10.1021/jm0492406
点击查看最新优质反应信息

文献信息

  • Ligands for Nicotinic Acetylcholine Receptors, and Methods of Making and Using Them
    申请人:Kozikowski Alan P.
    公开号:US20080132486A1
    公开(公告)日:2008-06-05
    One aspect of the present invention relates to heterocyclic compounds that are ligands for nicotinic acetylcholine receptors. A second aspect of the invention relates to the use of a compound of the invention for modulation of a mammalian nicotinic acetylcholine receptor. The present invention also relates to the use of a compound of the invention for treating a mammal suffering from Alzheimer's disease, Parkinson's disease, dyskinesias, Tourette's syndrome, schizophrenia, attention deficit disorder, anxiety, pain, depression, obsessive compulsive disorder, chemical substance abuse, alcoholism, memory deficit, pseudodementia, Ganser's syndrome, migraine pain, bulimia, obesity, premenstrual syndrome or late luteal phase syndrome, tobacco abuse, post-traumatic syndrome, social phobia, chronic fatigue syndrome, premature ejaculation, erectile difficulty, anorexia nervosa, disorders of sleep, autism, mutism or trichtillomania.
    本发明的一个方面涉及杂环化合物,其是乙酰胆碱受体的配体。本发明的第二个方面涉及使用本发明的化合物来调节哺乳动物的乙酰胆碱受体。本发明还涉及使用本发明的化合物来治疗患有阿尔茨海默病、帕金森病、运动障碍、抽动症、精神分裂症、注意力缺陷障碍、焦虑、疼痛、抑郁症、强迫症、化学物质滥用、酗酒、记忆力障碍、假性痴呆、甘瑟综合征、偏头痛疼痛、贪食症、肥胖症、月经前综合征或黄体酮期后综合征、烟草滥用、创伤后应激障碍、社交恐惧症、慢性疲劳综合征、早泄、勃起障碍、厌食症、睡眠障碍、自闭症、哑症或拔毛癖的哺乳动物。
  • US8030300B2
    申请人:——
    公开号:US8030300B2
    公开(公告)日:2011-10-04
  • Novel Pyridyl Ring C5 Substituted Analogues of Epibatidine and 3-(1-Methyl-2(<i>S</i>)- pyrrolidinylmethoxy)pyridine (A-84543) as Highly Selective Agents for Neuronal Nicotinic Acetylcholine Receptors Containing β2 Subunits
    作者:Zhi-Liang Wei、Yingxian Xiao、Hongbin Yuan、Maryna Baydyuk、Pavel A. Petukhov、John L. Musachio、Kenneth J. Kellar、Alan P. Kozikowski
    DOI:10.1021/jm0492406
    日期:2005.3.1
    Introduction of a hydrophobic or hydrogen-bonding alkynyl group into the C5 position of the pyridyl ring of epibatidine and A-84543 significantly increased the selectivity for neuronal nicotinic acetylcholine receptors (nAChRs) containing beta 2 subunits over nACbRs containing beta 4 subunits (K-i ratio up to 92000-fold). Our data indicate that the extracellular domains of the nAChRs are sufficiently different to allow for the design of novel ligands with high affinity and selectivity for the nAChR subtypes.
查看更多